Theriva Biologics, Inc.
TOVX
$0.21
-$0.01-5.94%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.53M | 12.12M | 10.01M | 11.61M | 16.41M |
| Total Receivables | 1.82M | 1.88M | 1.70M | 3.32M | 2.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 551.00K | 696.00K | 687.00K | 984.00K | 763.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 48.00K | 79.00K | 365.00K | 359.00K |
| Total Current Assets | 9.90M | 14.74M | 12.48M | 16.28M | 19.53M |
|
|
|||||
| Total Current Assets | 9.90M | 14.74M | 12.48M | 16.28M | 19.53M |
| Net Property, Plant & Equipment | 1.19M | 1.34M | 1.42M | 1.54M | 1.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.74M | 19.75M | 18.26M | 17.53M | 18.83M |
| Total Assets | 30.84M | 35.83M | 32.16M | 35.35M | 40.11M |
|
|
|||||
| Total Accounts Payable | 795.00K | 607.00K | 437.00K | 859.00K | 756.00K |
| Total Accrued Expenses | 8.43M | 9.78M | 4.32M | 4.51M | 5.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 675.00K | 668.00K | 619.00K | 600.00K | 606.00K |
| Total Finance Division Other Current Liabilities | 1.10M | 1.34M | 2.77M | 1.61M | 916.00K |
| Total Other Current Liabilities | 1.10M | 1.34M | 2.77M | 1.61M | 916.00K |
| Total Current Liabilities | 11.00M | 12.39M | 8.15M | 7.59M | 7.32M |
|
|
|||||
| Total Current Liabilities | 11.00M | 12.39M | 8.15M | 7.59M | 7.32M |
| Long-Term Debt | 1.65M | 1.64M | 1.50M | 92.00K | 98.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 433.00K | 584.00K | 732.00K | 873.00K | 1.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.01M | 10.59M | 6.28M | 7.74M | 7.02M |
| Total Liabilities | 24.10M | 25.21M | 16.66M | 16.29M | 15.47M |
|
|
|||||
| Common Stock & APIC | 362.98M | 362.47M | 355.60M | 355.50M | 355.34M |
| Retained Earnings | -356.71M | -352.35M | -339.30M | -334.97M | -330.53M |
| Treasury Stock & Other | 475.00K | 505.00K | -812.00K | -1.47M | -176.00K |
| Total Common Equity | 6.74M | 10.62M | 15.50M | 19.07M | 24.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.74M | 10.62M | 15.50M | 19.07M | 24.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.74M | 10.62M | 15.50M | 19.07M | 24.64M |
|
|
|||||